12
In addition to MIG, Samsung Electronics led the round through the Samsung Catalyst Fund
The investor in the Covid-19 vaccine developer BioNTech, MIG AG, is participating in a financing round of USD 20 million (EUR 16.49 million) in the robot start-up Bionic.
In addition to MIG, Samsung Electronics led the round through the Samsung Catalyst Fund, announced Bionic. The fresh money will be put into expansion.
Bionic describes itself as the first European manufacturer to develop and manufacture exoskeletons for use in industrial production.
